Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $386,888 | 113 | 72.9% |
| Travel and Lodging | $61,362 | 202 | 11.6% |
| Consulting Fee | $44,653 | 17 | 8.4% |
| Food and Beverage | $22,745 | 370 | 4.3% |
| Honoraria | $14,750 | 5 | 2.8% |
| Education | $196.48 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $345,052 | 441 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $67,502 | 67 | $0 (2024) |
| Inspire Medical Systems, Inc. | $38,020 | 43 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $29,507 | 40 | $0 (2017) |
| Avadel CNS Pharmaceuticals, LLC | $18,961 | 25 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $14,882 | 31 | $0 (2024) |
| Axsome Therapeutics, Inc. | $13,554 | 21 | $0 (2024) |
| ZOLL Respicardia, Inc. | $1,606 | 3 | $0 (2023) |
| Novo Nordisk Inc | $861.81 | 14 | $0 (2020) |
| Eisai Inc. | $198.91 | 12 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $145,745 | 168 | JAZZ PHARMACEUTICALS INC. ($92,000) |
| 2023 | $162,700 | 185 | Jazz Pharmaceuticals Inc. ($98,284) |
| 2022 | $53,256 | 67 | JAZZ PHARMACEUTICALS INC. ($28,625) |
| 2021 | $52,828 | 109 | JAZZ PHARMACEUTICALS INC. ($40,867) |
| 2020 | $29,617 | 57 | Jazz Pharmaceuticals Inc. ($29,195) |
| 2019 | $55,852 | 68 | JAZZ PHARMACEUTICALS INC. ($55,633) |
| 2018 | $409.02 | 5 | Jazz Pharmaceuticals Inc. ($324.30) |
| 2017 | $30,187 | 51 | Merck Sharp & Dohme Corporation ($29,507) |
All Payment Transactions
710 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,857.50 | General |
| Category: Insomnia | ||||||
| 12/04/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $113.14 | General |
| Category: Insomnia | ||||||
| 12/04/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $43.30 | General |
| Category: Insomnia | ||||||
| 12/04/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $36.67 | General |
| Category: Insomnia | ||||||
| 12/03/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $138.45 | General |
| Category: Insomnia | ||||||
| 11/28/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,690.00 | General |
| Category: NEUROLOGY | ||||||
| 11/25/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,762.50 | General |
| Category: Insomnia | ||||||
| 11/25/2024 | JAZZ PHARMACEUTICALS INC. | — | Food and Beverage | In-kind items and services | $126.48 | General |
| 11/22/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $554.44 | General |
| Category: Insomnia | ||||||
| 11/22/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $163.45 | General |
| Category: Insomnia | ||||||
| 11/22/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $122.71 | General |
| Category: NEUROLOGY | ||||||
| 11/21/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $199.22 | General |
| Category: Insomnia | ||||||
| 11/21/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $181.22 | General |
| Category: Insomnia | ||||||
| 11/20/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,762.50 | General |
| Category: Insomnia | ||||||
| 11/20/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Insomnia | ||||||
| 11/20/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $64.00 | General |
| Category: Insomnia | ||||||
| 11/16/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $340.68 | General |
| Category: Insomnia | ||||||
| 11/15/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $123.23 | General |
| Category: Insomnia | ||||||
| 11/13/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,762.50 | General |
| Category: Insomnia | ||||||
| 11/13/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $4.87 | General |
| Category: NEUROLOGY | ||||||
| 11/11/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $28.99 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 11/07/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,690.00 | General |
| Category: NEUROLOGY | ||||||
| 11/06/2024 | Resmed Corp | AIRSENSE (Device) | Food and Beverage | Cash or cash equivalent | $23.44 | General |
| Category: Sleep | ||||||
| 11/04/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $10.57 | General |
| Category: NEUROLOGY | ||||||
| 10/31/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $969.95 | General |
| Category: Insomnia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 842 | 1,336 | $322,202 | $136,350 |
| 2022 | 5 | 566 | 1,016 | $243,311 | $103,706 |
| 2021 | 7 | 466 | 759 | $176,832 | $77,749 |
| 2020 | 8 | 434 | 642 | $134,224 | $54,350 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 395 | 655 | $130,580 | $59,512 | 45.6% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 185 | 409 | $122,550 | $45,757 | 37.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 250 | 250 | $62,692 | $28,545 | 45.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 22 | $6,380 | $2,536 | 39.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 252 | 489 | $98,144 | $43,223 | 44.0% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2022 | 107 | 320 | $96,000 | $38,762 | 40.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 177 | 177 | $44,782 | $20,293 | 45.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 11 | $1,650 | $770.89 | 46.7% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2022 | 19 | 19 | $2,735 | $656.90 | 24.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 175 | 326 | $65,200 | $30,943 | 47.5% |
| 95800 | Study of sleep patterns, including sleep time | Office | 2021 | 72 | 179 | $53,700 | $23,289 | 43.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 149 | 149 | $37,250 | $17,742 | 47.6% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2021 | 21 | 54 | $7,016 | $2,411 | 34.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 27 | 29 | $4,350 | $1,910 | 43.9% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Office | 2021 | 11 | 11 | $7,810 | $1,060 | 13.6% |
| 95806 | Unattended sleep study with recording of heart rate, oxygen, respiratory airflow and effort | Facility | 2021 | 11 | 11 | $1,507 | $395.23 | 26.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 138 | 138 | $34,064 | $16,335 | 48.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 97 | 189 | $36,052 | $15,945 | 44.2% |
| 95800 | Study of sleep patterns | Office | 2020 | 47 | 82 | $23,700 | $9,853 | 41.6% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2020 | 24 | 93 | $12,083 | $4,458 | 36.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 56 | 67 | $10,484 | $3,793 | 36.2% |
| 95806 | Unattended sleep study with recording of heart rate, oxygen, respiratory airflow and effort | Office | 2020 | 26 | 27 | $9,306 | $2,186 | 23.5% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2020 | 12 | 12 | $7,200 | $1,296 | 18.0% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2020 | 34 | 34 | $1,336 | $483.70 | 36.2% |
About Dr. Vikas Jain, MD
Dr. Vikas Jain, MD is a Sleep Medicine healthcare provider based in Frisco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2008. The National Provider Identifier (NPI) number assigned to this provider is 1992965156.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vikas Jain, MD has received a total of $530,594 in payments from pharmaceutical and medical device companies, with $145,745 received in 2024. These payments were reported across 710 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($386,888).
As a Medicare-enrolled provider, Jain has provided services to 2,308 Medicare beneficiaries, totaling 3,753 services with total Medicare billing of $372,155. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Sleep Medicine
- Other Specialties Sleep Medicine, Sleep Medicine
- Location Frisco, TX
- Active Since 06/11/2008
- Last Updated 04/30/2024
- Taxonomy Code 207QS1201X
- Entity Type Individual
- NPI Number 1992965156
Products in Payments
- XYWAV (Drug) $220,503
- SUNOSI (Drug) $121,166
- QUVIVIQ (Drug) $67,502
- BELSOMRA (Drug) $29,507
- Inspire Upper Airway Stimulation System (Device) $21,524
- LUMRYZ (Drug) $18,961
- INSPIRE (Device) $16,497
- Sunosi (Drug) $13,554
- Wakix (Drug) $9,269
- WAKIX (Drug) $5,613
- remede System (Device) $1,606
- Saxenda (Drug) $660.82
- XYREM (Drug) $374.65
- Xyrem (Drug) $327.25
- Dayvigo (Drug) $198.91
- LifeVest (Device) $195.23
- Ozempic (Drug) $77.51
- WatchPAT (Device) $45.52
- AIRSENSE (Device) $38.61
- LINQ II (Device) $38.61
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Sleep Medicine Doctors in Frisco
Dr. Brent Stevenson, Do, DO
Sleep Medicine — Payments: $6,275
Jehangir Gowani, Md, MD
Sleep Medicine — Payments: $286.04
Dr. Michael William, Md, MD
Sleep Medicine — Payments: $145.58
Rejina Shrestha, Np, NP
Sleep Medicine